The Hindu Abbott Spices Up Drug Portfolio Wall Street Journal The American pharmaceutical company is buying the domestic drug-making business of India's Piramal Healthcare for nearly $3.72 billion.
View original post here:
Abbott Spices Up Drug Portfolio – Wall Street Journal
Otros Temas
THL Sells Michael Foods to Goldman Buyout Fund for $1.7 Billion – BusinessWeek
- Heard on the Street: Abbott Spices Up Drug Portfolio – Wall Street Journal
- Heard on the Street: Abbott Spices Up Drug Portfolio – Wall Street Journal
Postbank Quarterly Profit Declines as Bad-Loan Provisions Rise – BusinessWeek
Iceland volcano crisis will hit European airlines worse than US, experts say – Washington Post
Atlas rallies on $1.7 billion deal with India firm – MarketWatch
Provoking Google And Yahoo – ForbesNovell rejects $2 billion Elliott Associates offer – Reuters
Cnooc Forms $3.1 Billion Venture With Argentina’s Bridas – Wall Street Journal
US HOT STOCKS: Palm, Coca-Cola Enterprises, Express Scripts – Wall Street JournalSaks Posts Narrower Loss – Wall Street Journal
DreamWorks Animation Profit Falls 16%, Tops Estimates – BusinessWeekJPMorgan Nears Purchase of RBS Sempra Units for $1.7 Billion – BusinessWeek
Wal-Mart to cut 300 home-office staff – MarketWatch
Poniard Pharmaceuticals To Cut Jobs, Promotes Martell To CEO – Wall Street Journal
Tags: 1-7-billion, abbott-labs, business, includes-its, michael, news-articles, newswire, portfolio, ticker-magazine